Published by
@ShahidNShah
@ShahidNShah
May 21 to May 23, 2024
Hyatt Regency Boston, 1 Avenue de Lafayette, Boston, Massachusetts, 02111, United States
The 3rd ALS Drug Development Summit 2024, scheduled for May 21-23 in Boston, targets transformative ALS therapies, translational biomarkers, and clinical advancements. Attendees from diverse sectors like Biogen, Amylyx, and Sanofi convene to explore motor neuron degeneration complexities, discussing innovative models, biomarkers, and trial designs. The summit fosters forward-thinking dialogues, shaping meaningful endpoints and trial strategies for ALS treatment evolution. With industry leaders collaborating, the event drives progress in understanding and addressing ALS, offering hope to those affected and pushing the boundaries of ALS drug development.
[Read on als-drug-development.com/](https://www.als-drug-development.com/take-part/register/)
Continue reading at als-drug-development.com
May 22 to May 23, 2024
Chicago, United States of America
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Dec 18, 2024 at 12:33pm